Developmental delay, treatment-resistant psychosis, and early-onset dementia in a man with 22q11 deletion syndrome and Huntington’s Disease

Documenti analoghi

• Treatment-resistant psychotic symptoms and the 15q11.2 BP1–BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature
  di: Farrell, Martilias, et al.
  Pubblicazione: (2020)
• Improved Ethical Guidance for the Return of Results from Psychiatric Genomics Research
  di: Lázaro-Muñoz, Gabriel, et al.
  Pubblicazione: (2017)
• SA46. Comparison of Simple Reaction Times in Psychotic Inpatients With and Without Hyponatremia
  di: Filmyer, Dawn, et al.
  Pubblicazione: (2017)
• Vaptans Are Effective in Treating Hyponatremia in Psychotic Patients: But We Need Treatment Guidelines
  di: Josiassen, Richard C., et al.
  Pubblicazione: (2013)
• The Psychosis Spectrum in 22q11.2 Deletion Syndrome is Comparable to that of Non-Deleted Youths
  di: Tang, Sunny X., et al.
  Pubblicazione: (2016)